Reliv International, Inc (NASDAQ:RELV) Sees Significant Drop in Short Interest

Share on StockTwits

Reliv International, Inc (NASDAQ:RELV) was the recipient of a significant drop in short interest during the month of June. As of June 30th, there was short interest totalling 1,800 shares, a drop of 82.9% from the May 30th total of 10,500 shares. Currently, 0.2% of the shares of the company are short sold. Based on an average trading volume of 11,100 shares, the short-interest ratio is presently 0.2 days.

RELV stock traded down $0.02 during mid-day trading on Friday, hitting $4.58. 3,483 shares of the company were exchanged, compared to its average volume of 18,053. The business has a 50 day simple moving average of $4.65. The company has a quick ratio of 0.96, a current ratio of 1.42 and a debt-to-equity ratio of 0.01. Reliv International has a 1-year low of $3.80 and a 1-year high of $5.89.

Reliv International (NASDAQ:RELV) last issued its quarterly earnings data on Friday, May 10th. The company reported $0.36 earnings per share (EPS) for the quarter. The firm had revenue of $9.49 million during the quarter. Reliv International had a negative net margin of 2.92% and a negative return on equity of 8.49%.

About Reliv International

Reliv' International, Inc develops, manufactures, and markets nutritional supplements that address basic nutrition, wellness needs, weight management, and sports nutrition. Its nutritional supplements primarily include Reliv Classic and Reliv NOW, which are basic nutritional supplements containing a balanced blend of vitamins, minerals, proteins, and herbs; Innergize!, an isotonic sports supplement in two flavors; FibRestore, a high-fiber and antioxidant supplement; and LunaRich X, a soy concentrate with elevated levels of lunasin in capsule form.

Read More: Hold Rating

Receive News & Ratings for Reliv International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reliv International and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.